Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67

Journal of Surgical Oncology

Volumn 88, Issue 4, 2004, Pages 276-278

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN C;

BLEEDING; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FISTULA; HUMAN; LETTER; PERITONEUM CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPENDICEAL NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MITOMYCIN; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; SECOND-LOOK SURGERY;

EID: 10044251127     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20157     Document Type: Letter

References (17)

1. Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cyto-reductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004;85:61-67.
2. Gonzalez-Bayon L, Sugarbaker PH, Gonzalez-Moreno S, et al.: Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am 2003;12:741-754.
3. Loggie BW, Fleming RA: Complications of heated intraoperative chemotherapy and strategies for prevention. Cancer Treat Res 1996;82:221-233.
4. Jacquet P, Stephens AD, Averbach A, et al.: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-2629.
5. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality of 200 treatments with cytoreductive surgery and hyper thermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999;6:790-796.
6. Glehen O, Osinsky D, Cotte E, et al.: Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive patients. Ann Surg Oncol 2003;10:863-869.
7. Shen P, Hawksworth J, Lovato J, et al.: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004;11:178-186.
8. Schnake KJ, Sugarbaker PH, Yoo D: Neutropenia following perioperative intraperitoneal chemotherapy. Tumori 1999;85: 41-46.
9. Sugarbaker PH: Laser-mode electrosurgery. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: Principles of management. Kluwer: Boston; 1996 pp 375-385.
10. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132.
11. Sugarbaker PH: Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43:S15-S25.
12. Glehen O, Mithieux F, Osinsky AC, et al.: Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003;21:799-806.
13. Glehen O, Sugarbaker PH: Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004;240:278-285.
14. Sugarbaker PH: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-731.
15. Cunliffe WJ, Sugarbaker PH: Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy (EPIC). Br J Surg 1989;76:1082-1090.
16. Blair SL, Chu DZJ, Schwarz RE: Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecologic cancer. Ann Surg Oncol 2001;8:632-637.
17. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trail of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743.